相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
Yoshikazu Nakaoka et al.
RHEUMATOLOGY (2020)
Sub-antimicrobial doses of doxycycline decreased bone loss related to ligature-induced periodontitis in hypertensive rats
Gustavo H. A. Vieira et al.
ARCHIVES OF ORAL BIOLOGY (2019)
Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms
Carla Alvarez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Osteoimmunology: Inflammatory osteolysis and regeneration of the alveolar bone
Reinhard Gruber
JOURNAL OF CLINICAL PERIODONTOLOGY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Host modulation therapy with anti-inflammatory agents
Philip M. Preshaw
PERIODONTOLOGY 2000 (2018)
A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans
Nicolas Dutzan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Yoshikazu Nakaoka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The role and therapeutic targeting of IL-6 in rheumatoid arthritis
Masashi Narazaki et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier
Nicolas Dutzan et al.
IMMUNITY (2017)
Rosuvastatin promotes benefits on induced periodontitis in hypertensive rats
M. R. Messora et al.
JOURNAL OF PERIODONTAL RESEARCH (2017)
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Stefan Rose-John et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis
Ji-Hye Kim et al.
PLOS ONE (2017)
Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis
Mayu Morita et al.
SCIENTIFIC REPORTS (2017)
Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy
Xavier M. Teitsma et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity
E. Xiao et al.
CELL HOST & MICROBE (2017)
Ligature-induced periodontitis in mice induces elevated levels of circulating interleukin-6 but shows only weak effects on adipose and liver tissues
Y. Matsuda et al.
JOURNAL OF PERIODONTAL RESEARCH (2016)
Effects of Tocilizumab on Experimental Severe Acute Pancreatitis and Associated Acute Lung Injury
Ke-Ling Chen et al.
CRITICAL CARE MEDICINE (2016)
Effects of TNF-α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats
Morten Bay Grauballe et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2015)
Molecular aspects of the pathogenesis of periodontitis
Joerg Meyle et al.
PERIODONTOLOGY 2000 (2015)
Interleukin-6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors
Tetsuo Kobayashi et al.
CLINICAL AND EXPERIMENTAL DENTAL RESEARCH (2015)
Periodontitis: from microbial immune subversion to systemic inflammation
George Hajishengallis
NATURE REVIEWS IMMUNOLOGY (2015)
Assessment of Interleukin-6 Receptor Inhibition Therapy on Periodontal Condition in Patients With Rheumatoid Arthritis and Chronic Periodontitis
Tetsuo Kobayashi et al.
JOURNAL OF PERIODONTOLOGY (2014)
Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis
Keiko Shimamoto et al.
JOURNAL OF RHEUMATOLOGY (2013)
How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis?
Philip M. Preshaw et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2011)
Interleukin-6: From identification of the cytokine to development of targeted treatments
Eric Assier et al.
JOINT BONE SPINE (2010)
Periodontal Therapy Reduces Plasma Levels of Interleukin-6, C-Reactive Protein, and Fibrinogen in Patients With Severe Periodontitis and Refractory Arterial Hypertension
Fabio Vidal et al.
JOURNAL OF PERIODONTOLOGY (2009)
Periodontitis in systemic rheumatic diseases
Paola de Pablo et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Cytokines That Promote Periodontal Tissue Destruction
Dana Graves
JOURNAL OF PERIODONTOLOGY (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction
Kojiro Sato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Interleukin-6 receptor gene polymorphisms and periodontitis in a non-smoking Japanese population
Johnah C. Galicia et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2006)
Periodontitis and systemic inflammation: Control of the local infection is associated with a reduction in serum inflammatory markers
F D'Aiuto et al.
JOURNAL OF DENTAL RESEARCH (2004)
The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction
DT Graves et al.
JOURNAL OF PERIODONTOLOGY (2003)
分享论文
